Myriad mostly vindicated – for now
The Federal Circuit ruled today in Association for Molecular Pathology v the USPTO and Myriad Genetics that isolated DNA sequences are patent eligible, setting the stage for a Supreme Court battle over gene patents
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: